Overview

Join Dr. Sanjiv Chopra in this installment of Coffee with Chopra, as he interviews oncologist, Dr. Lowell Schnipper, about topics relevant to cancer detection, prevention, and treatment. Faculty will explain the interesting history which led to the development of various cancer treatments. This discussion will touch on immune-oncology, vaccines as cancer prevention, contributing factors to cancer risk and prevention, and lastly the emerging use of genomics in cancer detection. Join us for this conversation to learn about the “hot topics” in oncology. 

Learning Objectives

  • Outline the evolution and importance of various cancer treatments including monoclonal antibodies and other immunologic therapies
  • Identify the use of vaccines such as hepatitis B and human papillomavirus (HPV) for the prevention of cancer 
  • Recall environmental and lifestyle factors which lead to an increased risk of cancer
  • Summarize the use of genomics for early cancer diagnosis 

Faculty

Sanjiv Chopra, MD, MACP

Professor of Medicine
Harvard Medical School
Marshal Wolf Master Clinician Educator
Brigham and Women's Hospital
Boston, MA

 

Lowell E. Schnipper, MD

Distinguished Berenson Professor of Medicine, Oncology
Harvard Medical School
Boston, MA

 

Disclosures

The following relevant financial relationships have been disclosed by faculty: 

Sanjiv Chopra, MD, MACP: No relevant financial relationships disclosed.     

Lowell E. Schnipper, MD: No relevant financial relationships disclosed. 

 

Non-faculty contributors involved in the planning, development, editing, and review of the content have disclosed no relevant financial relationships. 


CME/CE Information

AMA PRA Category 1 Credits

Accreditation Statement

Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.


Designation Statement

Pri-Med Institute designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Once you have completed the activity, please click the "next" button to advance to the post-activity assessment. To complete this activity and claim credit, you must answer 2 out of 2 questions correctly. If you are not successful after your first attempt, you will be given an opportunity to reflect upon the answer rationales and have the opportunity to review the educational content before proceeding. Once you have selected your answers, click the "submit" button to complete the evaluation questions and proceed to the claim credit screen.                                                                                            For PAs, the NCCPA accepts for Category 1 CME credit activities designated for AMA PRA Category 1 Credit™.

Commercial Supporter

Not Applicable

Education Partner

Not Applicable


Fine Print

The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.

The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.

Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.

Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Essential Areas and Policies. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.

Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP. Pri-Med Institute is the accredited provider for this activity.

Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose relevant personal financial relationships with commercial interests prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to resolve real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. Financial disclosures are listed in the activity syllabus and will also be printed on the slides and announced at the start of each presentation.

Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.

Questions? If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.